Matrix Radiofrequency Combined with Myofascial Manipulation in the Treatment of Myofascial Pelvic Pain: A Retrospective Study.

Authors

Hongyan Wang, Wenying Wang, Fangfang Xue

Published in

International urogynecology journal. Jul 10, 2025. Epub Jul 10, 2025.

Abstract

This study is aimed at evaluating the clinical efficacy of matrix radiofrequency combined with myofascial manipulation in the treatment of myofascial pelvic pain (MPP) and to assess its effects on pain relief and pelvic floor muscle function improvement.
A retrospective analysis was conducted on the clinical data of 87 MPP patients treated at our hospital between January 2021 and December 2024. According to their treatment modalities, patients were divided into the observation group (matrix radiofrequency combined with myofascial manipulation) and the control group (myofascial manipulation alone). Pain levels and pelvic floor muscle function were assessed using the Visual Analog Scale (VAS) and pelvic floor surface electromyography by Glazer evaluation before and after treatment in both groups.
After the treatment course, the VAS scores significantly decreased in both groups. However, the post-treatment VAS score in the observation group (1.21 ± 0.95) was significantly lower than that in the control group (2.76 ± 0.80), with a statistically significant difference between the two groups (p < 0.001). The Glazer evaluation of pelvic floor muscles showed that the improvements in fast-twitch contraction, tonic contraction, and endurance contraction in the observation group were significantly greater than those in the control group (p < 0.001), and the reduction in resting electromyographic amplitude was also more pronounced. Moreover, the overall effective rate in the observation group was significantly higher than that in the control group (p < 0.05).
Matrix radiofrequency combined with myofascial manipulation is significantly more effective than myofascial manipulation alone in alleviating pain and improving pelvic floor muscle function in patients with MPP. This combination therapy provides a safe and effective treatment option, which can significantly improve the clinical efficacy of patients.

PMID:
40637859
Bibliographic data and abstract were imported from PubMed on 10 Jul 2025.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.